US 9062310
Compositions and methods for inhibiting expression of factor VII gene
granted A61PA61P29/00A61P31/12
Quick answer
US patent 9062310 (Compositions and methods for inhibiting expression of factor VII gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P29/00, A61P31/12, A61P43/00, A61P7/04